Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin

被引:95
作者
Fidler, KJ
Wilson, P
Davies, JC
Turner, MW
Peters, MJ
Klein, NJ
机构
[1] Inst Child Hlth, Portex Unit, Crit Care Grp, London WC1N 1EH, England
[2] Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England
[3] Royal Brompton & Natl Heart Hosp, London SW3 6NP, England
[4] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London WC1N 3JH, England
[5] Inst Child Hlth, Infect Dis & Microbiol Unit, London WC1N 1EH, England
关键词
systemic inflammatory response syndrome; sepsis; mannose-binding lectin; complement;
D O I
10.1007/s00134-004-2303-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To determine whether pediatric PICU patients with mannose-binding lectin (MBL) gene polymorphisms associated with low levels of the functional protein have an increased risk of developing sepsis and SIRS. Design and setting. A prospective, observational cohort study in a 22-bed PICU in a tertiary referral centre. Patients. One hundred consecutive admissions to a PICU with at least one organ system failure longer than 12 h. Patients were classified into those with infectious or non-infectious insults as the primary reason for intensive care admission. Patients were followed to determine which developed sepsis or non-infection related SIRS using standard criteria. Measurements and results. Of the 100 patients 50 had infectious and 50 had non-infectious insults as the precipitant for admission. 42 patients had variant MBL alleles (determined by MBL-2 gene exon 1 and promoter polymorphisms) and were significantly over-represented amongst the 59 patients that developed SIRS. This effect was not explained by differences in age, sex or ethnicity and was seen in both the infection and non-infection subgroups. In patients with infection, variant MBL alleles were associated with increased systemic response (2/15 with localised infection, 10/19 with sepsis and 12/16 with septic shock). MBL serum levels showed close concordance with the genotype and indicated that MBL levels less than 1000 ng/ml are associated with a greatly increased risk of SIRS. Conclusions. MBL-2 exon 1 polymorphisms with low serum levels of functional MBL protein are associated with a greatly increased risk of developing SIRS and of progression from infection to sepsis and septic shock in paediatric ICU patients.
引用
收藏
页码:1438 / 1445
页数:8
相关论文
共 37 条
[1]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]   The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation [J].
Brandtzaeg, P ;
Hogasen, K ;
Kierulf, P ;
Mollnes, TE .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :647-655
[5]   Continuing challenges of sepsis research [J].
Crowther, MA ;
Marshall, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1894-1896
[6]   Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics [J].
Garred, P ;
Richter, C ;
Andersen, AB ;
Madsen, HO ;
Mtoni, I ;
Svejgaard, A ;
Shao, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (02) :204-208
[7]   Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome [J].
Garred, P ;
Strom, JJ ;
Quist, L ;
Taaning, E ;
Madsen, HO .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (09) :1394-1403
[8]   Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease [J].
Garred, P ;
Pressler, T ;
Lanng, S ;
Madsen, HO ;
Moser, C ;
Laursen, I ;
Balstrup, F ;
Koch, C ;
Koch, C .
PEDIATRIC PULMONOLOGY, 2002, 33 (03) :201-207
[9]  
HAYDEN WR, 1993, CRIT CARE MED, V21, P1612, DOI 10.1097/00003246-199310000-00035
[10]  
Jack D, 1997, HUM MUTAT, V9, P41, DOI 10.1002/(SICI)1098-1004(1997)9:1<41::AID-HUMU7>3.3.CO